TJPC: Compound Amino Acids (15) Dipeptide (2) Injection has obtained a drug registration certificate
TJPC announced that its subsidiary TJPC HePing has obtained the drug registration certificate for Compound Amino Acid (15) Dipeptide (2) Injection issued by the National Medical Products Administration. This drug is used for parenteral nutrition therapy and is suitable for patients who cannot receive nutrition orally or through the gastrointestinal tract, especially those with moderate to severe catabolic states
According to the Zhitong Finance APP, TJPC (600488.SH) announced that its subsidiary Tianjin Pharmaceutical Co., Ltd. (hereinafter referred to as "Tianjin Pharmaceutical") has received the "Drug Registration Certificate" for Compound Amino Acids (15) Dipeptide (2) Injection (hereinafter referred to as "the drug" or "this product") approved and issued by the National Medical Products Administration.
The amino acids provided by Compound Amino Acids (15) Dipeptide (2) Injection are components of parenteral nutrition therapy, suitable for patients who cannot take nutrition orally or through the gastrointestinal tract, as well as those whose nutritional needs cannot be met through these routes, especially for patients with moderate to severe catabolic states
